HN

Honey Narang

Active Director Director DIN 08094406
DIN 08094406 First appointment Mar 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2018
Shareholding value •••• Premium profile

About Honey Narang

Data last updated:

Honey Narang is a Director at Revitos Healthcare Private Limited (since 2018). The company operates in Healthcare. Revitos Healthcare Private Limited reported revenue of ₹1.87 Cr (FY 2024).

DIN 08094406
Primary Designation Director
Industry Healthcare
First Appointment 23 Mar 2018
Oldest Company Age 8 yrs
Largest company Revitos Healthcare Private Limited · ₹1.87 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Revitos Healthcare Private Limited U74999UP2018PTC102439
Director23 Mar 20182018₹1.87 Cr (FY 2024)Active

Board colleagues of Honey Narang

Directorship timeline

Open interactive timeline →
Revitos Healthcare Private Limited
Premium access

Shareholding and investment profile for Honey Narang

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Honey Narang

Honey Narang currently holds 1 directorship: Revitos Healthcare Private Limited (Director, since 23 Mar 2018, revenue ₹1.87 Cr (FY 2024)).

Honey Narang was first appointed on 23 Mar 2018 as Director at Revitos Healthcare Private Limited.

The current boards of Honey Narang's companies include Grusha Rajpal (Revitos Healthcare Private Limited), Sunny Singh (Revitos Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available